Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil

BACKGROUND: Although high dose of antimony is the mainstay for treatment of American cutaneous leishmaniasis (ACL), ongoing major concerns remain over its toxicity. Whether or not low dose antimony regimens provide non-inferior effectiveness and lower toxicity has long been a question of dispute. ME...

詳細記述

保存先:
書誌詳細
出版年:PLoS One
主要な著者: Saheki, Mauricio Naoto, Lyra, Marcelo Rosandiski, Bedoya-Pacheco, Sandro Javier, Antônio, Liliane de Fátima, Pimentel, Maria Inês Fernandes, Salgueiro, Mariza de Matos, Vasconcellos, Érica de Camargo Ferreira e, Passos, Sonia Regina Lambert, dos Santos, Ginelza Peres Lima, Ribeiro, Madelon Novato, Fagundes, Aline, Madeira, Maria de Fátima, Mouta-Confort, Eliame, Marzochi, Mauro Célio de Almeida, Valete-Rosalino, Cláudia Maria, Schubach, Armando de Oliveira
フォーマット: Artigo
言語:Inglês
出版事項: Public Library of Science 2017
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5448803/
https://ncbi.nlm.nih.gov/pubmed/28558061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0178592
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料